Considering the above studies and the fact that microglia express both mGluR1 and mGluR5, the beneficial effects could result from a complex interplay of factors that indeed involve microglia, since they actively contribute to the pathological scenario of ischemic stroke. The gene discussed is GRM5; the disease is ischemic stroke.